-
Advantages
- Our combination not only affords T cell-mediated cytotoxicity but also preserves all the effectors of the function of Rituximab.
- Provides Lower Pricing! Since Naked Antibody is Less Sophisticated than Bispecific Antibody. And by Biosimilar, Price Could be Further Marked Down.
- The exploitation of approved Rituximab whose efficacy, specificity, and safety have been confirmed in clinics.
To find further information, please mail to contact@manysmart-t-cell.com